NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 872 filers reported holding NOVARTIS A G in Q1 2016. The put-call ratio across all filers is 0.75 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,092,346 | +13.3% | 9,925 | 0.0% | 0.21% | +11.6% |
Q1 2024 | $964,015 | -7.1% | 9,925 | -3.4% | 0.19% | -10.0% |
Q4 2023 | $1,037,467 | -0.9% | 10,275 | 0.0% | 0.21% | -11.0% |
Q3 2023 | $1,046,612 | +0.9% | 10,275 | 0.0% | 0.24% | +4.0% |
Q2 2023 | $1,036,850 | +9.7% | 10,275 | 0.0% | 0.23% | +5.1% |
Q1 2023 | $945,300 | +1.4% | 10,275 | 0.0% | 0.22% | -2.7% |
Q4 2022 | $932,148 | +19.4% | 10,275 | 0.0% | 0.22% | +15.0% |
Q3 2022 | $781,000 | -10.1% | 10,275 | 0.0% | 0.19% | -4.0% |
Q2 2022 | $869,000 | -3.7% | 10,275 | 0.0% | 0.20% | +14.2% |
Q1 2022 | $902,000 | +0.3% | 10,275 | 0.0% | 0.18% | +4.8% |
Q4 2021 | $899,000 | +13.2% | 10,275 | +5.8% | 0.17% | +7.7% |
Q3 2021 | $794,000 | -19.2% | 9,710 | -9.9% | 0.16% | -16.6% |
Q2 2021 | $983,000 | +6.7% | 10,772 | 0.0% | 0.19% | -0.5% |
Q1 2021 | $921,000 | -9.4% | 10,772 | 0.0% | 0.19% | -14.9% |
Q4 2020 | $1,017,000 | +1.7% | 10,772 | -6.3% | 0.22% | -9.1% |
Q3 2020 | $1,000,000 | -0.5% | 11,502 | 0.0% | 0.24% | -8.3% |
Q2 2020 | $1,005,000 | -10.9% | 11,502 | -16.0% | 0.26% | -22.5% |
Q1 2020 | $1,128,000 | -13.0% | 13,687 | 0.0% | 0.34% | +8.9% |
Q4 2019 | $1,296,000 | +4.3% | 13,687 | -4.3% | 0.31% | -2.2% |
Q3 2019 | $1,243,000 | -9.5% | 14,302 | -4.9% | 0.32% | -11.3% |
Q2 2019 | $1,373,000 | -2.3% | 15,032 | +2.8% | 0.36% | -9.3% |
Q1 2019 | $1,406,000 | +13.8% | 14,622 | +1.5% | 0.40% | -1.2% |
Q4 2018 | $1,236,000 | +25.7% | 14,402 | +26.3% | 0.40% | +49.6% |
Q3 2018 | $983,000 | +46.3% | 11,407 | +28.1% | 0.27% | +34.3% |
Q2 2018 | $672,000 | +99.4% | 8,902 | +113.5% | 0.20% | +79.5% |
Q1 2018 | $337,000 | +5.6% | 4,170 | +9.7% | 0.11% | +8.7% |
Q4 2017 | $319,000 | -2.1% | 3,800 | 0.0% | 0.10% | -8.0% |
Q3 2017 | $326,000 | -1.5% | 3,800 | -4.0% | 0.11% | -8.2% |
Q2 2017 | $331,000 | +29.8% | 3,960 | +16.3% | 0.12% | +23.2% |
Q1 2017 | $255,000 | +7.6% | 3,405 | +4.6% | 0.10% | 0.0% |
Q4 2016 | $237,000 | -3.3% | 3,255 | +4.8% | 0.10% | -10.0% |
Q3 2016 | $245,000 | -4.3% | 3,105 | 0.0% | 0.11% | -5.2% |
Q2 2016 | $256,000 | +13.8% | 3,105 | 0.0% | 0.12% | +6.4% |
Q1 2016 | $225,000 | -15.7% | 3,105 | 0.0% | 0.11% | -16.2% |
Q4 2015 | $267,000 | – | 3,105 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Martin Investment Management, LLC | 318,637 | $27,960,000 | 7.08% |
MANAGED ASSET PORTFOLIOS, LLC | 417,183 | $36,608,000 | 5.02% |
SAL Trading, LLC | 233,600 | $20,498,000 | 4.77% |
SCHARF INVESTMENTS, LLC | 1,340,680 | $117,662,000 | 3.49% |
SAL Trading, LLC | 155,783 | $13,670,000 | 3.18% |
First Fiduciary Investment Counsel, Inc. | 169,371 | $14,862,000 | 2.90% |
PRENTISS SMITH & CO INC | 55,026 | $4,829,000 | 2.90% |
GARLAND CAPITAL MANAGEMENT INC | 47,630 | $4,180,000 | 2.77% |
Cullen Capital Management, LLC | 3,295,271 | $289,160,000 | 2.66% |
WILKINS INVESTMENT COUNSEL INC | 133,880 | $11,748,000 | 2.65% |